These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19581846

  • 1. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
    Cheung WY, Neville BA, Earle CC.
    Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.
    Cancer; 2006 Dec 01; 107(11):2581-8. PubMed ID: 17078055
    [Abstract] [Full Text] [Related]

  • 4. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.
    Breast Cancer Res Treat; 2006 Oct 01; 99(3):313-21. PubMed ID: 16583264
    [Abstract] [Full Text] [Related]

  • 5. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.
    J Am Geriatr Soc; 2009 Aug 01; 57(8):1403-10. PubMed ID: 19563521
    [Abstract] [Full Text] [Related]

  • 6. Are survival rates different for young and older patients with rectal cancer?
    O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY.
    Dis Colon Rectum; 2004 Dec 01; 47(12):2064-9. PubMed ID: 15657655
    [Abstract] [Full Text] [Related]

  • 7. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM, Norwegian Gastrointestinal Cancer Group.
    Acta Oncol; 2009 Oct 01; 48(3):368-76. PubMed ID: 19242829
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD, Howlader N, Etzioni RD, Donato B.
    J Clin Oncol; 2004 Dec 15; 22(24):4971-8. PubMed ID: 15611512
    [Abstract] [Full Text] [Related]

  • 10. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 15; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):99-107. PubMed ID: 18407433
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study.
    Sigurdsson HK, Körner H, Dahl O, Skarstein A, Søreide JA, Norwegian Rectal Cancer Group.
    Dis Colon Rectum; 2007 Mar 01; 50(3):285-91. PubMed ID: 17235720
    [Abstract] [Full Text] [Related]

  • 15. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
    McGory ML, Zingmond DS, Sekeris E, Bastani R, Ko CY.
    Dis Colon Rectum; 2006 Mar 01; 49(3):319-29. PubMed ID: 16475031
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
    Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.
    J Clin Oncol; 2005 Dec 01; 23(34):8597-605. PubMed ID: 16314622
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
    Larsen SG, Wiig JN, Tretli S, Giercksky KE.
    Colorectal Dis; 2006 Mar 01; 8(3):177-85. PubMed ID: 16466556
    [Abstract] [Full Text] [Related]

  • 19. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Sep 01; 114(3):442-7. PubMed ID: 19560193
    [Abstract] [Full Text] [Related]

  • 20. Extended radical resection: the choice for locally recurrent rectal cancer.
    Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, Mackay J, Frizelle F.
    Dis Colon Rectum; 2008 Mar 01; 51(3):284-91. PubMed ID: 18204879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.